EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 348,00 INR
arrow_upward
+1,45%(+33,60) 1D
13-ноя., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 325,00 INR
High
2 395,00 INR
Low
2 315,40 INR
Mkt. cap
447,37 млд
Avg. vol.
229,26 миң
Volume
294,54 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,29
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
Open
2 325,00 INR
High
2 395,00 INR
Low
2 315,40 INR
Mkt. cap
447,37 млд
Avg. vol.
229,26 миң
Volume
294,54 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,29
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
News stories
From web sources and news partners
Yahoo! Finance Canada
·
4 мүнөт мурун
AMN,HLF,BSBK,FXNC,IMRX,CRMT,ORN,MRBK,FRST,TISI,GRNT,VSTS,GEF-B,RVSB,TMCI,DCGO,BCRX,SABR,SHEN,NBBK,USCB | Stock Prices | Quote Comparison - Yahoo Finance
Benzinga
·
14 мүнөт мурун
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
TheStreet
·
57 мүнөт мурун
Berkshire’s record high exposes hidden trap in S&P 500 401(k) plans
Bloomberg.com
·
1 күн мурун
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 миң
Founded1981-ж., 16-апр.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com